XELA
Watchlists:
Last updated: Saturday 15th February 2025
0.00
No Change
Prev Close:N/A
Open:N/A
Bid:N/A
Ask:N/A
52 Week Range
0.000.00
Volume:0
Mkt Cap:0 M
Financial Statements
XELA - Income Statement (Annual)
| Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Accrued Preferred Stock Dividends | 9 M | 7 M | 2 M | 1 M | 3 M | 4 M | 19 M | |||
| Acquired In Process Rn D | 3 M | |||||||||
| Depreciation And Amortization | 61 M | 72 M | 77 M | 94 M | 101 M | 139 M | 99 M | 80 M | ||
| Gain On Sale Of PPE | -556000.0 | -3 M | ||||||||
| Gain On Sale Of Security | 3 M | |||||||||
| General And Administrative Expense | 151 M | 177 M | 170 M | 186 M | 199 M | 185 M | 221 M | 130 M | 1 M | 53338.0 |
| Gross Profit Margin (profit Margin After CGS) | 1,064 M | 1,077 M | 278 M | 269 M | 338 M | 373 M | 323 M | 271 M | 500000.0 | |
| Impairment Of Capital Assets | 171 M | 350 M | 48 M | 69 M | ||||||
| Insurance And Claims | 0.0 | |||||||||
| Interest Expense Non Operating | 2 M | 165 M | 168 M | 174 M | 3 M | -1 M | ||||
| Interest Expense Operating | -144 M | -146 M | ||||||||
| Minority Interests | -723000.0 | |||||||||
| Misc Other Special Charges | 17 M | -19 M | 16 M | 25 M | -14 M | 3 M | -34 M | |||
| Net Income (loss) | -125 M | -416 M | -142 M | -179 M | -509 M | -170 M | -204 M | -48 M | -371927.0 | -53338.0 |
| Net Income Common Stockholders | -134 M | -423 M | -144 M | -180 M | -512 M | -173 M | -223 M | -48 M | -371927.0 | -53338.0 |
| Net Income Continuous Operations | 721 M | -416 M | -142 M | -179 M | -509 M | -170 M | -204 M | -48 M | -371927.0 | -53338.0 |
| Net Non Operating Interest Income Expense | -140 M | -165 M | -168 M | -174 M | -163 M | -156 M | -131 M | -109 M | 812000.0 | |
| Net Operating Interest Income Expense | 155807.0 | |||||||||
| Non Recurring Operation Expense | -63 M | |||||||||
| Operating Income | 8 M | -229 M | 21 M | -16 M | -321 M | 36 M | -30 M | 50 M | -527734.0 | -53338.0 |
| Operating Income Before Depreciation (EBITDA) | 798 M | -159 M | 131 M | 103 M | -530 M | -159 M | -153 M | 33 M | -72 M | -53338.0 |
| Operating Expense | 211 M | 248 M | 256 M | 285 M | 309 M | 336 M | 353 M | 221 M | 1 M | 53338.0 |
| Other Gand A | 151 M | 177 M | 170 M | 186 M | 199 M | 185 M | 221 M | 130 M | 1 M | 53338.0 |
| Other Impairment Of Capital Assets | 0.0 | |||||||||
| Other Operating Expenses | -88000.0 | -106000.0 | 9 M | 5 M | 10 M | 12 M | 33 M | 10 M | -110000.0 | |
| Otherunder Preferred Stock Dividend | 9 M | 7 M | 2 M | 1 M | 3 M | 4 M | 19 M | |||
| Preferred Stock Dividends | 9 M | 7 M | 2 M | 1 M | 3 M | 4 M | 19 M | |||
| Promotion And Advertising | 400000.0 | 500000.0 | 400000.0 | 700000.0 | 1 M | -900000.0 | ||||
| Rent And Landing Fees | -84 M | -60 M | -37 M | 1 M | 53338.0 | |||||
| Research Expense | 1 M | 2 M | 1 M | 1 M | 2 M | -2 M | ||||
| Restructring And Mn A Income | 0.0 | 0.0 | 121 M | |||||||
| Salaries And Wages | -149000.0 | 98000.0 | 10000.0 | 835000.0 | -8 M | 0.0 | -805000.0 | |||
| Selling And Marketing Expense | 400000.0 | 500000.0 | 400000.0 | 700000.0 | 1 M | -900000.0 | ||||
| Total Income Available For Interest Expense (EBIT) | 732 M | -247 M | 38 M | 9 M | -643 M | -308 M | -265 M | -60 M | -72 M | -53338.0 |
| Total Revenues | 1,064 M | 1,077 M | 1,167 M | 1,293 M | 1,562 M | 1,586 M | 1,152 M | 790 M | 500000.0 | |
| Total Expenses | 211 M | 248 M | 1,145 M | 1,309 M | 1,534 M | 1,550 M | 1,182 M | 740 M | 1 M | 53338.0 |
| Total Revenue | 1,064 M | 1,077 M | 1,167 M | 1,293 M | 1,562 M | 1,586 M | 1,152 M | 790 M | 805 M | |
| Amord | 174 M | 192 M | 367 M | 373 M | 375 M | 1 M | 2 M | 891000.0 | ||
| Avgshs | 6 M | 307966.0 | 29500.0 | 12286.0 | 12143.0 | 761719.0 | 491069.0 | 52072.0 | 51307.0 | 729.0 |
| Avgshsdt | 6 M | 307966.0 | 2828.0 | 415.0 | 437.0 | 745490.0 | 491069.0 | 52072.0 | 46490.0 | 444.0 |
| Basiceps | -22.37 | -1372.0 | -4880.0 | -14640.0 | -42240.0 | -218.0 | -416.0 | 2.0 | ||
| Basicepscont | -22.37 | -1372.0 | -4880.0 | -14640.0 | -42240.0 | -218.0 | -416.0 | 2.0 | ||
| Cor | 877 M | 889 M | 1,024 M | 1,225 M | 1,213 M | 829 M | 519 M | |||
| Depamor | 61 M | 72 M | 77 M | 94 M | 101 M | 139 M | 99 M | 80 M | ||
| Dileps | -22.37 | -1372.0 | -4920.0 | -14640.0 | -42240.0 | -218.0 | -416.0 | 2.0 | -8.0 | -120.0 |
| Dilepscont | -21.11 | -1372.0 | -4920.0 | |||||||
| Intinc | -140 M | -165 M | -168 M | -174 M | -163 M | -156 M | -128 M | -109 M | 812000.0 | |
| Netincdisc | -125 M | -416 M | -142 M | -179 M | -509 M | -170 M | -204 M | -48 M | -371927.0 | -53338.0 |
| Othincexp | -17 M | -189 M | -16 M | -25 M | 14 M | -6 M | 34 M | -1,333 M | ||
| Pretaxinc | -116 M | -411 M | -131 M | -165 M | -501 M | -161 M | -265 M | -60 M | -72 M | -53338.0 |
| Resdev | 1 M | 2 M | 1 M | 1 M | 2 M | -2 M | ||||
| Restruct | 0.0 | 0.0 | 121 M | |||||||
| Sga | 151 M | 177 M | 170 M | 186 M | 199 M | 185 M | 221 M | 130 M | 1 M | 53338.0 |
| Shsout | 6 M | 6 M | 95034.0 | 14742.0 | 12292.0 | 12511.0 | 12713.0 | 2404.0 | 28 M | 3645.0 |
| Specincchg | -171 M | 63 M | -350 M | -48 M | -69 M | -121 M | ||||
| Taxprov | 9 M | 4 M | 12 M | 14 M | 8 M | 8 M | -60 M | -12 M |